Literature DB >> 21554891

Loss of p120 catenin upregulates transcription of pro-inflammatory adhesion molecules in human endothelial cells.

James J O'Donnell1, Yan Zhuge, Oksana Holian, Feng Cheng, Larry L Thomas, Christopher B Forsyth, Hazel Lum.   

Abstract

P120 catenin (p120ctn) is an adherens junction protein recognized to regulate barrier function, but emerging evidence indicates that p120ctn may also exert control on other cellular functions such as transcriptional suppression of genes. We investigated the hypothesis that loss of p120ctn in human endothelial cells activates transcription of pro-inflammatory adhesion molecules. For study, siRNA targeted to p120ctn was transfected into brain microvascular (HBMECs) or pulmonary artery endothelial cells (HPAECs) for 24-120h, which depleted 50-80% of endogenous p120ctn. This loss of p120ctn resulted in increased promoter reporter activity of transcription factors, NFκB, AP-1, and Kaiso, as well as of target genes, MMP-1 and ICAM-1. Real-time RT-PCR analysis indicated that the mRNA for ICAM-1, VCAM-1, and E- and P-selectins were all upregulated during the period of 24-120h of p120ctn depletion, although the time-course and extent of the expression profiles differed. The upregulated mRNA of adhesion molecules corresponded with increased PMN adhesion to the EC surface and elevated ICAM-1 protein expression. We further explored the role of ERK1/2 as a potential signaling mechanism responsible for regulation of transcriptional activities by p120ctn. Results indicated that loss of p120ctn increased phosphorylated ERK1/2, and a MEK1 inhibitor (PD98059) prevented NFκB nuclear translocation. This implicates ERK1/2 in signaling the NFκB activation induced by p120ctn loss. The findings provide strong evidence that deficiency in p120ctn expression in endothelial cells is a potent stimulus for transcriptional upregulation of multiple adhesion molecules. We conclude that p120ctn functions to suppress transcription, which is an important and novel regulation in vascular endothelium.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554891      PMCID: PMC3149739          DOI: 10.1016/j.mvr.2011.04.008

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  42 in total

1.  Receptor protein-tyrosine phosphatase RPTPmu binds to and dephosphorylates the catenin p120(ctn).

Authors:  G C Zondag; A B Reynolds; W H Moolenaar
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

2.  Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole.

Authors:  C Hayne; G Tzivion; Z Luo
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

3.  The protein-tyrosine phosphatase SHP-1 binds to and dephosphorylates p120 catenin.

Authors:  H Keilhack; U Hellman; J van Hengel; F van Roy; J Godovac-Zimmermann; F D Böhmer
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

4.  Innate immune function of the adherens junction protein p120-catenin in endothelial response to endotoxin.

Authors:  Yan-Lei Wang; Yu Sun; Asrar B Malik; Sanyuan Hu; Albert B Reynolds; Richard D Minshall; Guochang Hu
Journal:  J Immunol       Date:  2011-01-28       Impact factor: 5.422

5.  Involvement of p120 in LPS-induced NF-kappaB activation and IL-8 production in human bronchial epithelial cells.

Authors:  Manxiang Wang; Naping Li; Jiansha Li; Yan Ma; Dan Li; Lingzhi Qin; Xi Wang; Renliang Wu
Journal:  Toxicol Lett       Date:  2010-02-19       Impact factor: 4.372

6.  Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer.

Authors:  Mirna Perez-Moreno; Weimin Song; H Amalia Pasolli; Scott E Williams; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

7.  Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.

Authors:  A M Domina; J H Smith; R W Craig
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

8.  P120 catenin represses transcriptional activity through Kaiso in endothelial cells.

Authors:  Jihang Zhang; James J O'Donnell; Oksana Holian; Peter A Vincent; Kwang S Kim; Hazel Lum
Journal:  Microvasc Res       Date:  2010-04-09       Impact factor: 3.514

9.  Inhibition of RhoA by p120 catenin.

Authors:  P Z Anastasiadis; S Y Moon; M A Thoreson; D J Mariner; H C Crawford; Y Zheng; A B Reynolds
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

Review 10.  Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades.

Authors:  A K Hubbard; R Rothlein
Journal:  Free Radic Biol Med       Date:  2000-05-01       Impact factor: 7.376

View more
  5 in total

1.  Control of vascular permeability by adhesion molecules.

Authors:  Ingrid H Sarelius; Angela J Glading
Journal:  Tissue Barriers       Date:  2015-04-03

2.  P120 catenin attenuates lipopolysaccharide-induced blood-brain barrier dysfunction and inflammatory responses in human brain microvascular endothelial cells.

Authors:  Na Liu; Ai-Li Li; Xiao-Ping Zhou; Qiang Chen; Wei Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 3.  p120-Catenin: a novel regulator of innate immunity and inflammation.

Authors:  Guochang Hu
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

4.  PKCδ null mutations in a mouse model of osteoarthritis alter osteoarthritic pain independently of joint pathology by augmenting NGF/TrkA-induced axonal outgrowth.

Authors:  Ranjan Kc; Xin Li; Jeffrey S Kroin; Zhiqiang Liu; Di Chen; Guozhi Xiao; Brett Levine; Jinyuan Li; John L Hamilton; Andre J van Wijnen; Margaret Piel; Daniel A Shelly; Dovrat Brass; Ela Kolb; Hee-Jeong Im
Journal:  Ann Rheum Dis       Date:  2016-01-18       Impact factor: 19.103

5.  P120 catenin attenuates the angiotensin II-induced apoptosis of human umbilical vein endothelial cells by suppressing the mitochondrial pathway.

Authors:  Yan Zhang; Chenshuang Zou; Shuwen Yang; Jing Fu
Journal:  Int J Mol Med       Date:  2016-02-01       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.